The Japanese Pharmaceutical Industry: Its Evolution and Current Challenges

Umemura, Maki (Author)

ISBN 10: 0415587662 / ISBN 13: 9780415587662

Published by Routledge, 2011

About this Item

1st edition. 208 pages. 9.57x6.42x0.67 inches. In Stock.

Seller Inventory # x-0415587662

Bibliographic Details

• Title: The Japanese Pharmaceutical Industry: Its Evolution and Current Challenges
• Publisher: Routledge
• Publication Date: 2011
• Language: English
• ISBN 10: 0415587662
• ISBN 13: 9780415587662
• Binding: Hardcover
• Condition: Brand New
• Weight: 0.45 kilograms

About this title

Synopsis

This book explores why Japan, despite being a world leader in many high technology industries such as automobiles and consumer electronics, is only a minor player in the global pharmaceutical industry. Japan provides a huge market for pharmaceuticals as the second largest consumer of prescription drugs after the United States, and is a massive importer of prescription drugs, relying on discoveries made elsewhere. This book charts the development of the industry, from the devastation resulting from the Second World War to its performance in the present day. Focusing in particular on antibiotics and anticancer drugs, the book analyses factors that have prevented Japan from leading the rapid advances in science and technology that have occurred globally over recent decades. Looking at the pharmaceutical industry, the book argues that the Japanese government’s research and development policies were not sufficiently incentivising. It also shows how the nature of capitalism in Japan - which featured close relations between government and industry as well as between and within firms - was appropriate for nurturing industrial development in the immediate post-war decades, but became much less effective in later years.

About the Author

Maki Umemura is a lecturer in Japanese studies at Cardiff Business School, Cardiff University, UK.